Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Miguel Polo Polo joins Hernández’s campaign and attacks Petro via Twitter May 31, 2022
- Listen to TV, Piero Angela at 93 still beats everyone with Superquark Jul 15, 2021
- Microsoft wants to release widgets in Windows 10 | Technology May 31, 2021
- Alonso: “Too bad, it cannot be defined as a ‘race’” | FormulaPassion.it Aug 30, 2021
- After Elizabeth II, decline or rebirth of the British monarchy? May 26, 2022
- Mexico vs Panama: schedule, TV channel in Mexico and the United States, online streaming and possible alignments Sep 7, 2021
- Presidential spokesman says the electrical system is returning to normal throughout the country May 22, 2022